IMPORTANT SAFETY
INFORMATION
When Not to Use OZURDEX®
OZURDEX® should not be used if you have any infections in or around the eyes, including most viral diseases of the cornea and conjunctiva, including active herpes viral infection of the eye, vaccinia, varicella, mycobacterial infections, and fungal diseases.
See more +
OZURDEX® should not be used if you have glaucoma that has progressed to a cup-to-disc ratio of greater than 0.8.
Full Prescribing InformationFor Healthcare Professionals
HOW IT WORKS
WHAT IS OZURDEX®?
A prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with:
OZURDEX® implant
size comparison.
OZURDEX® IS:
  • A tiny corticosteroid implant that slowly releases medication over time, without the need for monthly injections. It will dissolve naturally and will not need to be removed
  • Injected directly into the back of the eye, with minimal systemic absorption
WHAT DOES OZURDEX® DO?
Swollen Macula
Optical coherence tomography (OCT) image of the retina of a person with DME.
After Treatment
In clinical studies, OZURDEX® improved vision in patients without the need for monthly injections.
WHAT HAPPENS TO THE
OZURDEX® IMPLANT?
 
Approved Uses
OZURDEX® (dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used:
IMPORTANT SAFETY INFORMATION
When Not to Use OZURDEX®
OZURDEX® should not be used if you have any infections in or around the eyes, including most viral diseases of the cornea and conjunctiva, including active herpes viral infection of the eye, vaccinia, varicella, mycobacterial infections, and fungal diseases.
OZURDEX® should not be used if you have glaucoma that has progressed to a cup-to-disc ratio of greater than 0.8.
OZURDEX® should not be used if you have a posterior lens capsule that is torn or ruptured.
OZURDEX® should not be used if you are allergic to any of its ingredients.
Warnings and Precautions
Injections into the vitreous in the eye, including those with OZURDEX®, are associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal detachments. Your eye doctor should monitor you regularly after the injection.
Use of corticosteroids including OZURDEX® may produce posterior subcapsular cataracts, increased eye pressure, glaucoma, and may increase the establishment of secondary eye infections due to bacteria, fungi, or viruses. Let your doctor know if you have a history of ocular herpes simplex as corticosteroids are not recommended in these patients.
Common Side Effects in Diabetic Macular Edema
The most common side effects reported in patients with diabetic macular edema include: cataract, increased eye pressure, conjunctival blood spot, reduced vision, inflammation of the conjunctiva, specks that float in the field of vision, swelling of the conjunctiva, dry eye, vitreous detachment, vitreous opacities, retinal aneurysm, foreign body sensation, corneal erosion, inflammation of the cornea, anterior chamber inflammation, retinal tear, drooping eyelid, high blood pressure, and bronchitis.
Common Side Effects in Retinal Vein Occlusion and Uveitis
The most common side effects reported in patients for retinal vein occlusion and uveitis include: increased eye pressure, conjunctival blood spot, eye pain, eye redness, ocular hypertension, cataract, vitreous detachment, and headache.
Patient Counseling Information
After repeated injections with OZURDEX®, a cataract may occur. If this occurs, your vision will decrease and you will need an operation to remove the cataract and restore your vision. You may develop increased eye pressure with OZURDEX® that will need to be managed with eye drops, and rarely, with surgery.
In the days following injection with OZURDEX®, you may be at risk for potential complications including in particular, but not limited to, the development of serious eye infection or increased eye pressure. If your eye becomes red, sensitive to light, painful, or develops a change in vision, you should seek immediate care from your eye doctor. You may experience temporary visual blurring after receiving an injection and should not drive or use machinery until your vision has resolved.
Please click here for full Prescribing Information.
© 2022 AbbVie. All rights reserved.
All trademarks are the property of their respective owners.
US-OZU-220030  015462

This site is intended for U.S. consumers only. No information on this site is provided with the intention to give medical advice or instructions on the accurate use of Allergan products. Allergan cannot answer unsolicited emails requesting medical advice; visitors should always consult a healthcare professional. Please visit the Allergan website for your country of residence for information concerning Allergan products and services available there.

If you are new to Allergan and have non OZURDEX® related questions or concerns, call 1-844-NEW-2AGN (639-2246).
Full Prescribing Information Privacy Statement Terms of Use AbbVie.com Contact Us Cookies Settings